These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21346223)

  • 1. Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis.
    Kuhle J; Leppert D; Petzold A; Regeniter A; Schindler C; Mehling M; Anthony DC; Kappos L; Lindberg RL
    Neurology; 2011 Apr; 76(14):1206-13. PubMed ID: 21346223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
    Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of CSF neurofilament light and heavy chain protein in MS.
    Kuhle J; Plattner K; Bestwick JP; Lindberg RL; Ramagopalan SV; Norgren N; Nissim A; Malaspina A; Leppert D; Giovannoni G; Kappos L
    Mult Scler; 2013 Oct; 19(12):1597-603. PubMed ID: 23529999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
    Avsar T; Korkmaz D; Tütüncü M; Demirci NO; Saip S; Kamasak M; Siva A; Turanli ET
    Mult Scler; 2012 Aug; 18(8):1081-91. PubMed ID: 22252467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.
    Khademi M; Kockum I; Andersson ML; Iacobaeus E; Brundin L; Sellebjerg F; Hillert J; Piehl F; Olsson T
    Mult Scler; 2011 Mar; 17(3):335-43. PubMed ID: 21135023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofilament light as a prognostic marker in multiple sclerosis.
    Salzer J; Svenningsson A; Sundström P
    Mult Scler; 2010 Mar; 16(3):287-92. PubMed ID: 20086018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.
    Gunnarsson M; Malmeström C; Axelsson M; Sundström P; Dahle C; Vrethem M; Olsson T; Piehl F; Norgren N; Rosengren L; Svenningsson A; Lycke J
    Ann Neurol; 2011 Jan; 69(1):83-9. PubMed ID: 21280078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.
    Sola P; Mandrioli J; Simone AM; Ferraro D; Bedin R; Annecca R; Venneri MG; Nichelli PF; Merelli E
    Mult Scler; 2011 Mar; 17(3):303-11. PubMed ID: 21078694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies.
    Martin SJ; McGlasson S; Hunt D; Overell J
    J Neurol Neurosurg Psychiatry; 2019 Sep; 90(9):1059-1067. PubMed ID: 31123141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein.
    Kuhle J; Regeniter A; Leppert D; Mehling M; Kappos L; Lindberg RL; Petzold A
    J Neuroimmunol; 2010 Mar; 220(1-2):114-9. PubMed ID: 20117845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy.
    Eikelenboom MJ; Petzold A; Lazeron RH; Silber E; Sharief M; Thompson EJ; Barkhof F; Giovannoni G; Polman CH; Uitdehaag BM
    Neurology; 2003 Jan; 60(2):219-23. PubMed ID: 12552034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
    Komori M; Matsuyama Y; Nirasawa T; Thiele H; Becker M; Alexandrov T; Saida T; Tanaka M; Matsuo H; Tomimoto H; Takahashi R; Tashiro K; Ikegawa M; Kondo T
    Ann Neurol; 2012 May; 71(5):614-23. PubMed ID: 22522477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: implications for their possible immunopathogenic roles.
    Malmeström C; Andersson BA; Haghighi S; Lycke J
    J Neuroimmunol; 2006 Jun; 175(1-2):176-82. PubMed ID: 16626811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
    Kuhle J; Malmeström C; Axelsson M; Plattner K; Yaldizli O; Derfuss T; Giovannoni G; Kappos L; Lycke J
    Acta Neurol Scand; 2013 Dec; 128(6):e33-6. PubMed ID: 23763388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study.
    Petzold A; Steenwijk MD; Eikelenboom JM; Wattjes MP; Uitdehaag BM
    Mult Scler; 2016 Aug; 22(9):1154-62. PubMed ID: 27207456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofilaments as biomarkers in multiple sclerosis.
    Teunissen CE; Khalil M
    Mult Scler; 2012 May; 18(5):552-6. PubMed ID: 22492131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study.
    Haghikia A; Haghikia A; Hellwig K; Baraniskin A; Holzmann A; Décard BF; Thum T; Gold R
    Neurology; 2012 Nov; 79(22):2166-70. PubMed ID: 23077021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of tau phosphorylation state are associated with the clinical course of multiple sclerosis.
    Emeršič A; Karikari TK; Kac PR; Gonzalez-Ortiz F; Dulewicz M; Ashton NJ; Brecl Jakob G; Horvat Ledinek A; Hanrieder J; Zetterberg H; Rot U; Čučnik S; Blennow K
    Mult Scler Relat Disord; 2024 Oct; 90():105801. PubMed ID: 39153429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.